Abstract
We aimed to investigate BRAF V600E percentage immunohistochemically in ameloblastomas of a single institute cohort. We were interested if age, location, histological properties, or tumor recurrence depend on the BRAF status. We had 36 formalin-fixed, paraffin-embedded ameloblastoma tissue samples of patients treated at the Helsinki University Hospital between the years 1983-2016. Tissue sections underwent immunohistochemistry by Ventana BenchMark XT immunostainer using Ms Anti-Braf V600E (VE1) MAB. We used R 3.4.2 and RStudio 1.1.383 to conduct statistical analysis for BRAF positivity and earlier onset as well as tumor location. We used chi-squared tests and 2-by-2 table functions to determine connections between BRAF positivity and recurrence, growth pattern, and type. BRAF-positive tumors occurred in younger patients compared to BRAF-negative tumors (p = 0.015) and they located mostly to the mandible (p < 0.001). Growth patterns were limited to two in BRAF-negative tumors when BRAF-positive tumors presented with one to four growth patterns (p = 0.02). None of the maxillary tumors showed BRAF positivity and of these, 72.2% recurred. An immunohistochemical BRAF marker could be a beneficial tool to predict the outcome of patient...Continue Reading
References
Jan 16, 2007·International Journal of Oral and Maxillofacial Surgery·J HongP-H Choung
Jun 4, 2011·Acta Neuropathologica·David CapperAndreas von Deimling
Jan 1, 2014·The Journal of Pathology·Kari J KurppaKristiina Heikinheimo
May 27, 2014·Nature Genetics·Robert T SweeneyRobert B West
Jun 25, 2014·Nature Reviews. Cancer·Matthew HolderfieldMartin McMahon
Jul 6, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Noah A BrownBryan L Betz
Nov 16, 2014·Journal of Dental Research·K HeikinheimoP R Morgan
Apr 10, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Marina Gonçalves DinizRicardo Santiago Gomez
Aug 27, 2015·Oral Oncology·P BrunnerS Hoeller
Oct 21, 2015·Biomarkers in Cancer·Noah A Brown, Bryan L Betz
Sep 30, 2016·Histopathology·Eduardo R FregnaniFábio A Alves
Oct 11, 2016·Journal of Oral and Maxillofacial Pathology : JOMFP·Ravleen NagiN Rakesh
Nov 24, 2016·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Sungjin A SongPhilip D Littlefield
Apr 30, 2017·Journal of the Egyptian National Cancer Institute·Adel K El-Naggar
Nov 2, 2017·Oncotarget·Monika SzymonekAldona Kowalska
Jun 2, 2018·Clinical Oral Investigations·Alan Motta do CantoPaulo Henrique Braz-Silva
Sep 14, 2018·BMC Cancer·Gustavo S FernandesEduardo R Fregnani
Sep 15, 2018·Journal of Dental Research·K HeikinheimoP R Morgan
Nov 9, 2018·Acta Odontologica Scandinavica·Jetta KelppeHanna Thorén
Citations
Oct 28, 2019·Neuroscience Bulletin·Wenping MaHongshan Zhao
Nov 25, 2020·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Adepitan A OwoshoKurt F Summersgill
Dec 31, 2020·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Maria Sissa Pereira Sant'AnaFelipe Paiva Fonseca
May 4, 2021·Frontiers in Immunology·Wenping MaYing Zhang
Jul 16, 2020·Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology·Puangwan LapthanasupkulNakarin Kitkumthorn